Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) continued to trade lower on Wednesday as Wolfe Research downgraded the cystic fibrosis drugmaker after the company’s Q1 2025 financials fell short of ...

J.P. Morgan’s David Kelly, Wolfe Research’s Stephanie Roth and Morgan Stanley’s Jim Caron, join 'Power Lunch' to discuss the Fed's decision to leave rates unchanged.